Clinical Trial

Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients

Completed Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to find out whether Vitamin E (Alpha tocopherol), taken alone or together with Psyllium husk (a type of dietary fibre), can improve blood fat levels in adults with dyslipidaemia (abnormal blood levels of two types of fat: cholesterol and triglycerides). The main questions this study aims to answer are: * Does Vitamin E (400 mg/day) alone help lower blood cholesterol and triglyceride levels? * Does combining Vitamin E (400 mg/day) with Psyllium husk (10 g/day) lead to better results compared to participants taking Vitamin E alone? Researchers will compare all three groups i.e. Group A taking Vitamin E alone, Group B taking Vitamin E and Psyllium husk and Group C receiving a placebo (a look alike supplement). The hypothesis of the study is that 'There is a noticeable difference between all the three study groups.' Participants will: * Take their assigned (specific to the concerned group under study) treatment daily for 60 days. * Visit study place every two weeks for follow-up. * Have blood tests done at the beginning and end of the study to check for changes in cholesterol and triglyceride levels.
Trial Details
NCT Number NCT07610304
Lead Sponsor NUR International University
Conditions Dyslipidaemia
Enrollment 60 participants
Start Date 2022-06-15
Primary Completion 2022-08-15 (estimated)
Study Completion 2022-08-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-27